Pharma Excipients

Polyethylene Glycol

Effect of formulation composition on trastuzumab stability

Abstract For monoclonal antibody drug products as for other biologics, while the innovator drug products first becomes commercially available, they are often followed by one or more biosimilar products. These biosimilars often differ from the innovator product, as well as from each other, in…
Read More...